Forest Devices, Inc., a medical device startup based in Pittsburgh, Pennsylvania, has successfully secured $1.3 million in investment capital. This funding round marks a significant milestone for the company, known for developing SignalNED, a rapid EEG device designed to enhance stroke detection. The investment will support the company's ongoing efforts to bring its innovative technology to the healthcare market.
SignalNED is described as a fast, reliable, and accurate rapid EEG system that provides users with clear quantitative EEG (qEEG) results. Forest Devices' core mission revolves around creating a more effective method for detecting stroke and enabling informed decisions that directly contribute to an improved quality of life for patients post-stroke. The company also aims to decrease the burden on the healthcare system and the patient’s loved ones through its technology. This capital infusion is expected to accelerate the realization of these critical objectives.
The newly raised funds are earmarked to advance the development and commercialization of SignalNED. Forest Devices plans to utilize the capital for key growth initiatives, including further product refinement, scaling operational capabilities, and preparing for regulatory approvals and market launch. This investment reflects investor confidence in Forest Devices' innovative approach to addressing a critical need in neurological emergency care.
Looking ahead, Forest Devices is focused on expanding its reach and impact within the medical community. The company anticipates that this funding will be instrumental in accelerating its trajectory towards becoming a pivotal player in stroke diagnostics, ultimately contributing to better patient outcomes and more efficient healthcare delivery globally.
